Xaar PLC
17 October 2000
Xaar plc
Board Changes
Xaar plc, the Cambridge-based inkjet technology company,
has today announced the following board changes. It has
been mutually agreed that Graham Wylie will resign as
Chief Executive Officer with immediate effect. The Board
has appointed Jan Fineman, previously Group Operations
Director, as his successor.
Commenting on the changes, Arie Rosenfeld, Chairman, said
'Graham has achieved a great deal in taking Xaar from its
earliest days as a small R and D house to our
position today as a key player at the forefront of the
digital printing revolution. We thank him for all his
efforts and dedication and wish him well for the future.
The Board has now chosen Jan Fineman as the new Chief
Executive to lead Xaar through the next exciting phase of
its growth in rapidly changing markets. Inkjet is now
widely accepted as a key technology for the entire
printing industry, not just desktop printing; Xaar has
enormous potential to emerge as one of the leading
players in a global industry that is now demanding
digital solutions. We believe that Jan and the senior
executive team have the right skills to capitialise on
that potential.'
Jan Fineman, aged 41, is a Swedish national, who has had
responsibility for all aspects of operations at Xaar,
including technology development, engineering and
manufacturing. He has been with Xaar since April 1999
when the company of which he was Managing Director,
Modular Ink Technology (MIT), was acquired by Xaar.
Prior to joining MIT, he held senior technical,
operational, strategic planning and general management
roles in the life science instrumentation division of
Pharmacia, (subsequently spun out as Biacore AB), and
the semiconductor division of ABB. He holds an MSc in
chemical engineering for The Royal Institute of
Technology in Stockholm.
Xaar
Arie Rosenfeld, Chairman 01223-423663
Jonathan Lowe, Finance Director
Buchanan Communications
Lisa Baderoon 020-7466-5000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.